Activators of REEP2 function through a variety of biochemical mechanisms to influence its activity within the cell. Compounds that elevate intracellular cAMP levels, such as those that directly stimulate adenylyl cyclase or inhibit phosphodiesterase, lead to an increase in PKA activity. The subsequent phosphorylation cascade can result in the enhanced phosphorylation and activation of REEP2, as phosphorylation is a common regulatory mechanism for protein activation. Similarly, a cell-permeable cAMP analog can directly activate PKA, bypassing upstream signaling and exerting a similar effect on REEP2. Other activators include agents that modulate ion channel function, such as chloride channel blockers and sodium channel activators. By altering neuronal excitability, these compounds may indirectly initiate signaling events that culminate in the activation of REEP2, as changes in ion gradients and cellular excitability are known to influence a myriad of signaling pathways.
Additionally, compounds that interfere with cellular trafficking, such as those which disrupt ER to Golgi transport, could indirectly lead to the activation of REEP2 by affecting its localization and function within the cell. Certain natural compounds are known to modulate multiple signaling pathways, including those that influence PKA activity. Chemicals that modulate ion channel function might play a role in the indirect activation of REEP2 by perturbing cellular signaling on a broader scale. Lastly, alkaloids that promote sodium channel activation can increase neuronal activity and hence may influence pathways associated with REEP2 activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Phosphodiesterase inhibitor that prevents cAMP degradation, maintaining PKA activation, which can lead to the phosphorylation and activation of REEP2. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Selective phosphodiesterase 4 inhibitor, increasing cAMP levels and thus PKA activity, potentially leading to the phosphorylation and activation of REEP2. | ||||||
Picrotoxin | 124-87-8 | sc-202765 sc-202765A sc-202765B | 1 g 5 g 25 g | $67.00 $286.00 $1326.00 | 11 | |
A chloride channel blocker that can alter neuronal excitability, indirectly affecting pathways that may involve the activation of REEP2. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Inhibits Na+/K+-ATPase, affecting ion gradients and cellular excitability, which can lead to the activation of signaling pathways involving REEP2. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts ER to Golgi transport, affecting cellular trafficking pathways that could indirectly lead to the activation of REEP2. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Modulates various signaling pathways, including the PKA pathway, which could lead to the activation of REEP2 through phosphorylation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Cell-permeable cAMP analog that activates PKA, potentially resulting in the phosphorylation and activation of REEP2. | ||||||
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | $96.00 $160.00 $240.00 $405.00 | 26 | |
Activates TRPV1 channels, influencing calcium signaling and potentially affecting pathways that lead to the activation of REEP2. | ||||||
Veratridine | 71-62-5 | sc-201075B sc-201075 sc-201075C sc-201075A | 5 mg 10 mg 25 mg 50 mg | $82.00 $104.00 $201.00 $379.00 | 3 | |
Alkaloid that activates sodium channels, leading to increased neuronal excitability and potentially the activation of REEP2-associated pathways. | ||||||